Voyager Therapeutics VYGR
NASDAQ VYGR
$3.39 +0.07 (+2.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2015 - 2026)

Voyager Therapeutics (VYGR) posted Amortizatization of Intangibles of $365000.0 for Q1 2026, down 31.13% sequentially from $530000.0 in Q4 2025, and down 63.43% YoY from $998000.0 in Q1 2025.

Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends

Voyager Therapeutics has reported Amortizatization of Intangibles for 12 years, with the latest figure at $365000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 63.43% year-over-year to $365000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 66.74% YoY) and the FY2025 annual result came in at $3.0 million, down 62.69% from the prior year.
  • Amortizatization of Intangibles slipped to $365000.0 in Q1 2026 per VYGR's latest filing, from $530000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $2.5 million in Q2 2024 and troughed at -$21000.0 in Q1 2022.
  • A 5-year average of $879352.9 and a median of $654000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles soared 30700.0% in 2024, then plunged 68.27% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at -$7000.0 in 2022, then surged by 25728.57% to $1.8 million in 2023, then fell by 15.66% to $1.5 million in 2024, then plunged by 64.97% to $530000.0 in 2025, then sank by 31.13% to $365000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $365000.0, $530000.0, and $654000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Voyager Therapeutics 205.86 Mn 89.52 Mn - 1.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 248,000.00
Jun 30, 2026 248,000.00
Mar 31, 2026 365,000.00
Mar 31, 2026 365,000.00
Dec 31, 2025 530,000.00
Dec 31, 2025 530,000.00
Sep 30, 2025 654,000.00
Sep 30, 2025 654,000.00
Jun 30, 2025 791,000.00
Jun 30, 2025 791,000.00
Mar 31, 2025 998,000.00
Mar 31, 2025 998,000.00
Dec 31, 2024 1.51 Mn
Dec 31, 2024 1.51 Mn
Sep 30, 2024 2.06 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 2.46 Mn
Jun 30, 2024 2.46 Mn
Mar 31, 2024 1.93 Mn
Mar 31, 2024 1.93 Mn